HLA-C and Miyoshi myopathy: The association of neoantigen load with decreased survival on standard induction therapy does not preclude the role of genomic instability, DNA repair, MM clonal heterogeneity, or reduced MHC expression could have on clinical outcome and the function of neoantigens.